Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05591677. We help you review the study, but cannot decide medical eligibility.
Active Not RecruitingNCT05591677
D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression: A Multi-Site, study (COGENT)
This study is active but not recruiting in Australia. It is testing D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) for depression.
DepressionDrugOver 18 Years
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Melbourne, AustraliaSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 21, 2023
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 180
- Sponsor
- The Alfred
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Australia
- Age range
- Over 18 Years
- Official registry ID
- NCT05591677
- Official title
- D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression: A Multi-Site, Randomised, Placebo-Controlled Trial (COGENT)
Recruitment & locations
Not recruitingMelbourne
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is The Alfred.
Does this study involve medication?
Yes. The study involves medication, including D-Cycloserine.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Active Not RecruitingACTRN12623000832673
Treatment Resistant Depression Intervention with Psilocybin-assisted Psychotherapy
This study is active but not recruiting. It focuses on depression and currently lists study information in Australia.
Active Not RecruitingACTRN12617000494336
A Case Series Evaluation of a Brief Behavioural Activation Intervention for Pathological Grief
This study is active but not recruiting. It focuses on prolonged grief disorder and currently lists study information in Australia.
Active Not RecruitingNCT07224347
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
This study is active but not recruiting. It focuses on depression and currently lists study information in Australia and the United States.